In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia

Several recent clinical trials have successfully incorporated a costimulatory domain derived from either CD28 or 4-1BB with the original CD3ζ T cell activating domain to form second-generation chimeric antigen receptors (CARs) that can increase the responsiveness and survival of CAR-engineered T (CA...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Ther
Egile Nagusiak: Cheng, Zhi, Wei, Runhong, Ma, Qiuling, Shi, Lin, He, Feng, Shi, Zixiao, Jin, Tao, Xie, Ronglin, Wei, Baofeng, Chen, Jing, Fang, Hongliang, Han, Xiaolu, Rohrs, Jennifer A., Bryson, Paul, Liu, Yarong, Li, Qi-Jing, Zhu, Bo, Wang, Pin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Gene & Cell Therapy 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079368/
https://ncbi.nlm.nih.gov/pubmed/29503204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.01.022
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak